Boehringer Ingelheim Group, which is one of the world's largest manufacturers of biologic medicines, has declared that the US Food and Drug Administration (FDA) has approved its high-concentration, citrate-free formulation of Cyltezo (adalimumab...
In the glistening ambiance of success and camaraderie, the stage was set for an evening of unparalleled splendor and distinction as the maiden edition of Pharma Quality Excellence Awards 2024 unfolded in all its grandeur.
Novartis, a leading innovative medicines company, has announced its intention to acquire Mariana Oncology, a US-based biotechnology firm that specializes in the development of novel radioligand therapies (RLTs) to treat cancers with a high unmet...
ClearPoint Neuro, a global therapy-enabling platform, and quality treatment empowering organization offering exact route to the brain and spine, declared it has secured 510(k) approval for its Prism Bone Anchor Accessory. The company's second new...
Pfizer Inc, a pharmaceutical industry firm and Genmab A/S reported that the US Food and Drug Administration (FDA) endorses the supplemental Biologics License Application (sBLA) giving full endorsement for Tivdak (tisotumab vedotin-tftv) for the...
The US FDA endorsed the utilization of a sprinkle case plan of Neurocrine Biosciences Ingrezza (valbenazine) for the treatment of tardive dyskinesia and chorea in Huntington's illness. The US FDA endorsed the utilization of a sprinkle case plan.....
.jpg)
.jpg)
